U.S. pharmaceutical giant,  Pfizer on Tuesday, said that the company had exceeded its goal of manufacturing 3 billion doses of Comirnaty, the Pfizer-BioNTech COVID-19 vaccine, in 2021 and was heading towards a record profit. The company also increased its 2022 revenue guidance for Comirnaty, reflecting doses expected to be delivered under supply contracts signed as … Continue reading Pfizer Heading For Record Profit From COVID-19 Vaccine